Annual ROE
-83.39%
+110.52%+57.00%
December 31, 2023
Summary
- As of February 8, 2025, ELEV annual return on equity is -83.39%, with the most recent change of +110.52% (+57.00%) on December 31, 2023.
- During the last 3 years, ELEV annual ROE has fallen by -158.19% (-211.48%).
- ELEV annual ROE is now -211.48% below its all-time high of 74.80%, reached on December 31, 2020.
Performance
ELEV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-59.73%
-1.76%-3.04%
September 30, 2024
Summary
- As of February 8, 2025, ELEV quarterly return on equity is -59.73%, with the most recent change of -1.76% (-3.04%) on September 30, 2024.
- Over the past year, ELEV quarterly ROE has stayed the same.
- ELEV quarterly ROE is now -174.94% below its all-time high of 79.70%, reached on March 31, 2021.
Performance
ELEV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ELEV ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.0% | 0.0% |
| 3 y3 years | -211.5% | +45.9% |
| 5 y5 years | - | +45.9% |
ELEV ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -266.2% | +57.0% | -94.6% | +61.0% |
| 5 y | 5-year | -211.5% | +57.0% | -174.9% | +61.0% |
| alltime | all time | -211.5% | +57.0% | -174.9% | +61.0% |
Elevation Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -59.73%(+3.0%) |
| Jun 2024 | - | -57.97%(-2.3%) |
| Mar 2024 | - | -59.35%(-27.6%) |
| Dec 2023 | -83.39%(-57.0%) | -81.92%(-21.7%) |
| Sep 2023 | - | -104.60%(-31.7%) |
| Jun 2023 | - | -153.17%(+2.8%) |
| Mar 2023 | - | -149.04%(+35.1%) |
| Dec 2022 | -193.91% | -110.33%(+40.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -78.52%(+72.4%) |
| Jun 2022 | - | -45.55%(+46.7%) |
| Mar 2022 | - | -31.06%(+1.2%) |
| Dec 2021 | -22.77%(-130.4%) | -30.69%(-37.8%) |
| Sep 2021 | - | -49.35%(-22.3%) |
| Jun 2021 | - | -63.52%(-179.7%) |
| Mar 2021 | - | 79.70%(+6.6%) |
| Dec 2020 | 74.80% | 74.80% |
FAQ
- What is Elevation Oncology annual return on equity?
- What is the all time high annual ROE for Elevation Oncology?
- What is Elevation Oncology annual ROE year-on-year change?
- What is Elevation Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Elevation Oncology?
- What is Elevation Oncology quarterly ROE year-on-year change?
What is Elevation Oncology annual return on equity?
The current annual ROE of ELEV is -83.39%
What is the all time high annual ROE for Elevation Oncology?
Elevation Oncology all-time high annual return on equity is 74.80%
What is Elevation Oncology annual ROE year-on-year change?
Over the past year, ELEV annual return on equity has changed by +110.52% (+57.00%)
What is Elevation Oncology quarterly return on equity?
The current quarterly ROE of ELEV is -59.73%
What is the all time high quarterly ROE for Elevation Oncology?
Elevation Oncology all-time high quarterly return on equity is 79.70%
What is Elevation Oncology quarterly ROE year-on-year change?
Over the past year, ELEV quarterly return on equity has changed by 0.00% (0.00%)